Satyam, S.M.; El-Tanani, M.; Patni, M.A.; Rehman, A.; Wali, A.F.; Rangraze, I.R.; Babiker, R.; Rabbani, S.A.; El-Tanani, Y.; Rizzo, M.
Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole. Antibiotics 2025, 14, 459.
https://doi.org/10.3390/antibiotics14050459
AMA Style
Satyam SM, El-Tanani M, Patni MA, Rehman A, Wali AF, Rangraze IR, Babiker R, Rabbani SA, El-Tanani Y, Rizzo M.
Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole. Antibiotics. 2025; 14(5):459.
https://doi.org/10.3390/antibiotics14050459
Chicago/Turabian Style
Satyam, Shakta Mani, Mohamed El-Tanani, Mohamed Anas Patni, Abdul Rehman, Adil Farooq Wali, Imran Rashid Rangraze, Rasha Babiker, Syed Arman Rabbani, Yahia El-Tanani, and Manfredi Rizzo.
2025. "Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole" Antibiotics 14, no. 5: 459.
https://doi.org/10.3390/antibiotics14050459
APA Style
Satyam, S. M., El-Tanani, M., Patni, M. A., Rehman, A., Wali, A. F., Rangraze, I. R., Babiker, R., Rabbani, S. A., El-Tanani, Y., & Rizzo, M.
(2025). Repurposing Anthelmintic Drugs for COVID-19 Treatment: A Comprehensive Meta-Analysis of Randomized Clinical Trials on Ivermectin and Mebendazole. Antibiotics, 14(5), 459.
https://doi.org/10.3390/antibiotics14050459
